Aarti Pharmalabs Limited (BOM:543748)
India · Delayed Price · Currency is INR 706.50
+30.40 (4.50%)
At close: Apr 21, 2026
Aarti Pharmalabs Revenue
Aarti Pharmalabs had revenue of 4.32B INR in the quarter ending December 31, 2025, a decrease of -19.62%. This brings the company's revenue in the last twelve months to 18.01B, down -12.47% year-over-year. In the fiscal year ending March 31, 2025, Aarti Pharmalabs had annual revenue of 21.15B with 14.17% growth.
Revenue (ttm)
18.01B
Revenue Growth
-12.47%
P/S Ratio
3.56
Revenue / Employee
8.33M
Employees
2,162
Market Cap
64.07B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 21.15B | 2.62B | 14.17% |
| Mar 31, 2024 | 18.53B | -926.24M | -4.76% |
| Mar 31, 2023 | 19.45B | 7.45B | 62.11% |
| Mar 31, 2022 | 12.00B | - | - |
| Mar 31, 2021 | - | - | - |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Jubilant Pharmova | 79.18B |
| Caplin Point Laboratories | 20.92B |
| FDC Limited | 20.78B |
| Sanofi India | 18.37B |
| Viyash Scientific | 18.17B |
| Rubicon Research | 15.98B |
| Procter & Gamble Health | 13.49B |
| CORONA Remedies | 13.44B |